No Data
No Data
Kazia Therapeutics To Carry Out 1-for-10 Reverse Stock Split On October 28th, 2024
Breast Cancer Awareness Month Sees Biotech Advancements and Worrying Trends for Young Women
Kazia Therapeutics Adjusts ADS Ratio to Boost Nasdaq Listing
Express News | Kazia Therapeutics- Plans to Change Ratio of Adss to One Ads Representing 100 Ordinary Shares
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Kazia Therapeutics Announces Presentation of Promising Phase I Data Evaluating Concurrent Paxalisib and Radiation Therapy in Patients With Solid Tumor Brain Metastases or Leptomeningeal Metastases Harboring PI3K Pathway Mutations at the American...